Valeritas Holdings, Inc. (VLRX) financial statements (2021 and earlier)

Company profile

Business Address 750 ROUTE 202 SOUTH
BRIDGEWATER, NJ 08807
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments   47243314
Cash and cash equivalents   47243314
Receivables6666654
Inventory, net of allowances, customer advances and progress billings9987778
Inventory9987778
Other undisclosed current assets2529382111
Total current assets:40435162384628
Noncurrent Assets
Operating lease, right-of-use asset22 
Property, plant and equipment7776666
Other noncurrent assets1100100
Other undisclosed noncurrent assets  2    
Total noncurrent assets:101097766
TOTAL ASSETS:49536069455334
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8886565
Accounts payable5565344
Accrued liabilities3322111
Taxes payable   0000
Debt11 0000
Deferred compensation liability5434432
Other undisclosed current liabilities5454433
Total current liabilities:19171514131111
Noncurrent Liabilities
Long-term debt and lease obligation22 0000
Finance lease, liability0  
Capital lease obligations0000
Operating lease, liability22 
Liabilities, other than long-term debt, including:1742410393837
Due to related parties17424140393837
Other liabilities 00 000
Other undisclosed liabilities, other than long-term debt   (40)   
Other undisclosed noncurrent liabilities  140   
Total noncurrent liabilities:19444340393837
Total liabilities:38615854525048
Stockholders' equity
Stockholders' equity attributable to parent, including:11(8)114(7)3(14)
Preferred stock 000000
Common stock0000000
Treasury stock, value(0)(0)(0)(0)(0)(0)(0)
Additional paid in capital573541536534501499471
Accumulated deficit(562)(549)(535)(520)(508)(496)(486)
Other undisclosed stockholders' equity attributable to parent0      
Total stockholders' equity:11(8)114(7)3(14)
TOTAL LIABILITIES AND EQUITY:49536069455334

Income statement (P&L) ($ in millions)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Revenues8867766
Cost of revenue
(Cost of Goods and Services Sold)
(4)(4)(3)(4)(4)(3)(3)
Gross profit:4433333
Operating expenses(16)(17)(17)(14)(14)(13)(14)
Operating loss:(12)(13)(14)(11)(11)(10)(11)
Nonoperating expense(1)(1)(1)(1)(1)(1)(1)
Interest and debt expense(1)(1)(1)3(1)(1)(1)
Loss from continuing operations before equity method investments, income taxes:(14)(15)(16)(9)(12)(12)(13)
Other undisclosed income (loss) from continuing operations before income taxes111(3)111
Net loss attributable to parent:(13)(14)(15)(12)(12)(11)(12)
Preferred stock dividends and other adjustments(1)(1)(1)(1)(1)(1)(1)
Net loss available to common stockholders, diluted:(14)(15)(15)(12)(12)(12)(12)

Comprehensive Income ($ in millions)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Net loss:(13)(14)(15)(12)(12)(11)(12)
Comprehensive loss, net of tax, attributable to parent:(13)(14)(15)(12)(12)(11)(12)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: